Joseph D. Miller

15.1k citations

81 papers · 9.1k indexed · 6 hit papers · h-index 41

Immunology top 0.5%
Molecular Biology top 5%
Infectious Diseases top 1%
Cellular and Molecular Neuroscience top 1%
Epidemiology top 2%

Co-authors: Rafi Ahmed John D. Altman Kaja Murali‐Krishna David Sourdive Jill E. Slansky Allan Zajac M. Suresh Rebecca A. Prosser
Topics: Circadian rhythm and melatonin (21 papers)Immune Cell Function and Interaction (12 papers)Photoreceptor and optogenetics research (11 papers)
Cited by: Immunology Endocrine and Autonomic Systems Virology
Journals: Science Proceedings of the National Academy of Sciences JAMA
Partner nations: United States France United Kingdom

In The Last Decade

Joseph D. Miller

81 papers receiving 8.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection

1998 1.7k citations Kaja Murali‐Krishna, John D. Altman et al. Immunity profile →
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

2005 959 citations Andrew M. Intlekofer, Naofumi Takemoto et al. Nature Immunology profile →
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

2008 809 citations Rama Akondy, Dirk E. Teuwen et al. Nature Immunology profile →
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

1993 590 citations Timothy W. Lovenberg, Luı́s de Lecea et al. Neuron profile →
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

2022 403 citations Emma K. Accorsi, Amadea Britton et al. profile →
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023

2023 76 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by Joseph D. Miller

Since Specialization

Citations

This map shows the geographic impact of Joseph D. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph D. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph D. Miller more than expected).

Fields of papers citing papers by Joseph D. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph D. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph D. Miller. The network helps show where Joseph D. Miller may publish in the future.

Co-authorship network of co-authors of Joseph D. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph D. Miller. A scholar is included among the top collaborators of Joseph D. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph D. Miller. Joseph D. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023 2023 ·MMWR Morbidity and Mortality Weekly Report ·Katherine E. Fleming-Dutra,Allison Avrich Ciesla,Lauren E. Roper,Zachary Smith,Joseph D. Miller,Emma K. Accorsi,Jennifer R. Verani,Nong Shang,Gordana Derado,Ryan E. Wiegand,Tamara Pilishvili,Amadea Britton,Ruth Link‐Gelles	11
2	Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023breakdown → 2023 ·MMWR Morbidity and Mortality Weekly Report ·Ruth Link‐Gelles,Allison Avrich Ciesla,Lauren E. Roper,Heather M. Scobie,Akilah R. Ali,Joseph D. Miller,Ryan E. Wiegand,Emma K. Accorsi,Jennifer R. Verani,Nong Shang,Gordana Derado,Amadea Britton,Zachary Smith,Katherine E. Fleming-Dutra	76
3	Theories and Treatment of Drug Dependency: A Neurochemical Perspective 2015 ·Current Molecular Pharmacology ·(unknown),Richard E. Wilcox,Joseph D. Miller	2
4	Improved specificity and reduced subtype cross-reactivity for antibody detection by ELISA using globular head domain recombinant hemagglutinin 2014 ·Journal of Virological Methods ·(unknown),P.J. Carney,Seh‐Ching Lin,Ji Li,Jessie Chang,Vic Veguilla,James Stevens,Joseph D. Miller,Min Z. Levine,Jacqueline M. Katz,Kathy Hancock	7
5	Detecting 2009 Pandemic Influenza A (H1N1) Virus Infection: Availability of Diagnostic Testing Led to Rapid Pandemic Response 2010 ·Clinical Infectious Diseases ·Daniel B. Jernigan,(unknown),(unknown),Joseph D. Miller,Michael Höelscher,(unknown),(unknown),Lynnette Brammer,Stephen A. Burke,Julie Villanueva,Amanda Balish,Timothy M. Uyeki,Desiree Mustaquim,Amanda M. Bishop,(unknown),(unknown),Xinyi Xu,Alexander Klimov,Nancy J. Cox,Michael W. Shaw	72
6	The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response 2009 ·The Journal of Immunology ·Rama Akondy,(unknown),Joseph D. Miller,Srilatha Edupuganti,Dirk E. Teuwen,Hong Wu,(unknown),Seema Garg,John D. Altman,Carlos del Rı́o,Harry Keyserling,Alexander Ploß,Charles M. Rice,Walter A. Orenstein,Mark J. Mulligan,Rafi Ahmed	239
7	Molecular signature of human virus specific effector CD8+ T cells (83.20) 2009 ·The Journal of Immunology ·Rama Akondy,Joseph D. Miller,Gregory Doho,Hong Wu,Michael J. Zilliox,(unknown),Mark J. Mulligan,Srilatha Edupuganti,W. Nicholas Haining,Rafi Ahmed	1
8	Perspectives 2006 ·Humana Press eBooks ·Shao‐Yao Ying,Donald C. Chang,Joseph D. Miller,Shi-Lung Lin	6
9	HypothesisConcurrent HLA-related response factors mediate recombinant hepatitis B vaccine major adverse events 2005 ·Autoimmunity ·Joseph D. Miller,(unknown)	5
10	Effector and memory CD8+ T cell fate coupled by T-bet and eomesoderminbreakdown → 2005 ·Nature Immunology ·Andrew M. Intlekofer,Naofumi Takemoto,E. John Wherry,Sarah Longworth,(unknown),V. Palanivel,Alan C. Mullen,(unknown),Susan M. Kaech,Joseph D. Miller,Laurent Gapin,Kenneth Ryan,Andreas Russ,Tullia Lindsten,Jordan S. Orange,Ananda W. Goldrath,Rafi Ahmed,Steven L. Reiner	959
11	Analysis of HLA-E Peptide-Binding Specificity and Contact Residues in Bound Peptide Required for Recognition by CD94/NKG2 2003 ·The Journal of Immunology ·Joseph D. Miller,Dominique A. Weber,Chris Ibegbu,Jan Pohl,John D. Altman,Peter E. Jensen	113
12	A Transgenic Mouse Model Genetically Tags All Activated CD8 T Cells 2003 ·The Journal of Immunology ·Charles H. Maris,Joseph D. Miller,John D. Altman,Joshy Jacob	23
13	CD8 Binding to MHC Class I Molecules Is Influenced by T Cell Maturation and Glycosylation 2001 ·Immunity ·Mark A. Daniëls,Lesley Devine,Joseph D. Miller,Janice M. Moser,Aron E. Lukacher,John D. Altman,Paula Kavathas,Kristin A. Hogquist,Stephen C. Jameson	161
14	Developmental changes in nicotinic receptor mRNAs and responses to nicotine in the suprachiasmatic nucleus and other brain regions 1999 ·Molecular Brain Research ·Bruce F. O’Hara,(unknown),(unknown),(unknown),Rozi Andretić Waldowski,Vinh H. Cao,Joseph D. Miller,H. Craig Heller,Thomas S. Kilduff	28
15	Direct Assessment of MHC Class I Binding by Seven Ly49 Inhibitory NK Cell Receptors 1999 ·Immunity ·Thomas Hanke,Hisao Takizawa,Christopher W. McMahon,Dirk H. Busch,Eric G. Pamer,Joseph D. Miller,John D. Altman,Yang Liu,Dragana Cado,François A. Lemonnier,Pamela J. Björkman,David H. Raulet	264
16	Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infectionbreakdown → 1998 ·Immunity ·Kaja Murali‐Krishna,John D. Altman,M. Suresh,David Sourdive,Allan Zajac,Joseph D. Miller,Jill E. Slansky,Rafi Ahmed	1716
17	Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer 1996 ·Journal of Biological Chemistry ·Eric R. Schuur,Gail Henderson,(unknown),Joseph D. Miller,Henry Lamparski,Daniel Henderson	253
18	A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythmsbreakdown → 1993 ·Neuron ·Timothy W. Lovenberg,(unknown),Luı́s de Lecea,Joseph D. Miller,Rebecca A. Prosser,Michael A. Rea,Pamela E. Foye,Margaret M. Racke,(unknown),Barry W. Siegel,Patria E. Danielson,J G Sutcliffe,Mark G. Erlander	590
19	Serotonergic phase shifts of the mammalian circadian clock: effects of tetrodotoxin and high Mg2+ 1992 ·Brain Research ·Rebecca A. Prosser,H. Craig Heller,Joseph D. Miller	51
20	The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation 1990 ·Brain Research ·Joseph D. Miller,Charles A. Fuller	52

About Joseph D. Miller

Joseph D. Miller is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Virology, having authored 81 papers that have together received 9.1k indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (21 papers), Immune Cell Function and Interaction (12 papers) and Photoreceptor and optogenetics research (11 papers). The work is most often cited by research in Immunology (4.3k citations), Endocrine and Autonomic Systems (1.2k citations) and Virology (459 citations). Joseph D. Miller has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Rafi Ahmed, John D. Altman, Kaja Murali‐Krishna, David Sourdive, Jill E. Slansky, Allan Zajac, M. Suresh, Rebecca A. Prosser, H. Craig Heller and Dale M. Edgar. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact